Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Immutep Announce Notice of initial substantial holder (ASX:IMM)

Form 603 For further information please download the attached PDF:

Immutep Announce Change in Substantial Holding (ASX:IMM)

Form 604 - Notice of change of interests of the substantial holder. For further information please download the attached PDF:

Integrated Payment Technologies Ltd announce ISO 27001 Certification (ASX:IP1)

ISO accreditation points to continued focus by InPayTech on strategic initiatives Sydney, Thursday 18 July 2019 Integrated Payment Technologies Limited (InPayTech) (ASX: IP1) announces that it h...read more

Immutep announce Mailing of Offer Booklet for Entitlement Offer (ASX:IMM)

Immutep Limited (ASX Code: IMM) – Mailing of Offer Booklet for Entitlement Offer Immutep Limited (ASX: IMM) (Immutep or the Company) is pleased to announce that it has today mailed a copy of ...read more

Immutep release Cleansing Notice (ASX:IMM)

Notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) To view, please download the attached PDF:

Immutep Announce Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b) (ASX:IMM)

Immutep Limited (ASX:IMM) (the Company), confirms the issue today of 190,476,191 fully paid ordinary shares, pursuant to the placement and appendix 3B announced to ASX on 9 July 2019. The shares raise...read more

Imugene Enhances Portfolio with Compelling Oncolytic Virus (ASX:IMU)

Imugene Enhances Portfolio with Compelling Oncolytic Virus from City of Hope, a Cancer Centre in Los Angeles, California FDA Investigational New Drug (IND) package Worldwide, exclusive...read more

Immutep release Cleansing Notice (ASX:IMM)

Immutep Limited (ASX Code: IMM) Notice under section 708AA(2)(f) of the Corporations Act 2001 (Cth) For further information please download the attached PDF:

Immutep release Letter to Ineligible Shareholders (ASX:IMM)

Immutep Limited Entitlement Offer - Notification to ineligible shareholders For further information please download the attached PDF:

Immutep release Letter to Eligible Shareholders (ASX:IMM)

Pro rata non-renounceable entitlement offer to raise approximately A$6 million For further information please download the attached PDF:

Immutep Release Appendix 3B (ASX:IMM)

Appendix 3B New issue announcement, application for quotation of additional securities and agreement For further information please download the attached PDF:

Immutep Entitlement Offer Booklet (ASX:IMM)

Immutep Limited ACN 009 237 889 (IMM or Company) Details of a 1-for 11.8 non-renounceable entitlement offer (Entitlement Offer) of new fully paid ordinary shares in the Company (New Shares) at a pr...read more

Immutep Capital Raising Presentation (ASX:IMM)

A global leader in developing LAG-3 therapeutics Capital Raising Presentation July 2019 For more information please download the attached PDF:

Immutep raises A$10M via Placement and Underwritten Entitlement Offer (ASX:IMM)

Approximately A$10 million being raised to drive development of immuno-oncology and autoimmune programs and pursue regulatory pathways for lead product candidate, eftilagimod alpha Capita...read more

Imugene Announce New HER-Vaxx Cancer Vaccine trial data presented at ESMO GI (ASX:IMU)

New HER-Vaxx Cancer Vaccine trial data presented at the European Society of Medical Oncology World Congress on Gastrointestinal Cancer SYDNEY, Australia, 8 July 2019: Imugene Limited (ASX:IMU), a c...read more

Viewing: 1 - 15 of 200 Previous | Next